Cardiovascular Risk Assessment in Patients Treated With Caduet (RIGHT)

January 26, 2021 updated by: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Cardiovascular Risk Assessment In Patients With Hypertension And At Least Three Other Risk Factors, Treated With Caduet Compared To Usual Care: The Right Study

Compare the reduction in Framingham's predicted 10-year risk of a coronary event (6) in patients with hypertension and at least three other cardiovascular risk factors (including diabetic patients) seen in private practice and randomized to either Caduet or usual care.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
1442

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Abbeville, France, 80100
        • Pfizer Investigational Site
      • Aire Sur La Lys, France, 62120
        • Pfizer Investigational Site
      • Aix Les Bains, France, 73100
        • Pfizer Investigational Site
      • Alencon, France, 61000
        • Pfizer Investigational Site
      • Allaire, France, 56350
        • Pfizer Investigational Site
      • Amboise, France, 37400
        • Pfizer Investigational Site
      • Amiens, France, 80000
        • Pfizer Investigational Site
      • Amiens, France, 80080
        • Pfizer Investigational Site
      • Amiens Cedex 3, France, 80094
        • Pfizer Investigational Site
      • Andrezieux Boutheon, France, 42160
        • Pfizer Investigational Site
      • Angers, France, 49000
        • Pfizer Investigational Site
      • Annecy, France, 74000
        • Pfizer Investigational Site
      • Annecy Le Vieux, France, 74940
        • Pfizer Investigational Site
      • Annemasse, France, 74100
        • Pfizer Investigational Site
      • Anzin, France, 59410
        • Pfizer Investigational Site
      • Appoigny, France, 89380
        • Pfizer Investigational Site
      • Apt, France, 84400
        • Pfizer Investigational Site
      • Argenteuil, France, 95100
        • Pfizer Investigational Site
      • Arles, France, 13200
        • Pfizer Investigational Site
      • Arneke, France, 59285
        • Pfizer Investigational Site
      • Arpajon, France, 91290
        • Pfizer Investigational Site
      • Arsac, France, 33460
        • Pfizer Investigational Site
      • Aubagne, France, 13400
        • Pfizer Investigational Site
      • Auchel, France, 62260
        • Pfizer Investigational Site
      • Audresselles, France, 62164
        • Pfizer Investigational Site
      • Autrans, France, 38880
        • Pfizer Investigational Site
      • Balma, France, 31130
        • Pfizer Investigational Site
      • Bastia, France, 20200
        • Pfizer Investigational Site
      • Bayonne, France, 64100
        • Pfizer Investigational Site
      • Beaucaire, France, 30300
        • Pfizer Investigational Site
      • Beaumont Les Valence, France, 26760
        • Pfizer Investigational Site
      • Beaurains, France, 62217
        • Pfizer Investigational Site
      • Beausoleil, France, 06240
        • Pfizer Investigational Site
      • Belley, France, 01300
        • Pfizer Investigational Site
      • Belpech, France, 11420
        • Pfizer Investigational Site
      • Benquet, France, 40280
        • Pfizer Investigational Site
      • Berck, France, 62600
        • Pfizer Investigational Site
      • Bersee, France, 59235
        • Pfizer Investigational Site
      • Bethune, France, 62400
        • Pfizer Investigational Site
      • Beziers, France, 34500
        • Pfizer Investigational Site
      • Biarritz, France, 64200
        • Pfizer Investigational Site
      • Blasimon, France, 33540
        • Pfizer Investigational Site
      • Blois, France, 41000
        • Pfizer Investigational Site
      • Boen, France, 42130
        • Pfizer Investigational Site
      • Boersch, France, 67530
        • Pfizer Investigational Site
      • Bondues, France, 59910
        • Pfizer Investigational Site
      • Bondy, France, 93140
        • Pfizer Investigational Site
      • Bordeaux, France, 33000
        • Pfizer Investigational Site
      • Bordeaux, France, 33200
        • Pfizer Investigational Site
      • Bourg St. Andeol, France, 07700
        • Pfizer Investigational Site
      • Bourges, France, 18000
        • Pfizer Investigational Site
      • Brehan, France, 56580
        • Pfizer Investigational Site
      • Brest, France, 29200
        • Pfizer Investigational Site
      • Brignoud, France, 38190
        • Pfizer Investigational Site
      • Bruay La Buissiere, France, 62700
        • Pfizer Investigational Site
      • Cabestany, France, 66330
        • Pfizer Investigational Site
      • Caen, France, 14000
        • Pfizer Investigational Site
      • Cagnes Sur Mer, France, 06800
        • Pfizer Investigational Site
      • Cannes, France, 06400
        • Pfizer Investigational Site
      • Cannes La Bocca, France, 06150
        • Pfizer Investigational Site
      • Carnon Plage, France, 34280
        • Pfizer Investigational Site
      • Castelnau Le Fez, France, 34170
        • Pfizer Investigational Site
      • Castelsarrasin, France, 82100
        • Pfizer Investigational Site
      • Castres, France, 81100
        • Pfizer Investigational Site
      • Caylus, France, 82160
        • Pfizer Investigational Site
      • Cergy, France, 95000
        • Pfizer Investigational Site
      • Cestas, France, 33610
        • Pfizer Investigational Site
      • Champagne Au Mont D'Or, France, 69410
        • Pfizer Investigational Site
      • Chanceaux Sur Choisille, France, 37390
        • Pfizer Investigational Site
      • Charleville Mezieres, France, 08000
        • Pfizer Investigational Site
      • Chartres, France, 28000
        • Pfizer Investigational Site
      • Chatou, France, 78400
        • Pfizer Investigational Site
      • Chelles, France, 77500
        • Pfizer Investigational Site
      • Chenove, France, 21300
        • Pfizer Investigational Site
      • Chilly Mazarin, France, 91380
        • Pfizer Investigational Site
      • Clairac, France, 47320
        • Pfizer Investigational Site
      • Clary, France, 59225
        • Pfizer Investigational Site
      • Clermont Ferrand, France, 63100
        • Pfizer Investigational Site
      • Collioure, France, 66190
        • Pfizer Investigational Site
      • Colombier Fontaine, France, 25260
        • Pfizer Investigational Site
      • Colomiers, France, 31770
        • Pfizer Investigational Site
      • Condat Sur Vienne, France, 87920
        • Pfizer Investigational Site
      • Courthezon, France, 84350
        • Pfizer Investigational Site
      • Craponne, France, 69290
        • Pfizer Investigational Site
      • Crecy La Chapelle, France, 77580
        • Pfizer Investigational Site
      • Crest, France, 26400
        • Pfizer Investigational Site
      • Creteil, France, 94000
        • Pfizer Investigational Site
      • Crotenay, France, 39300
        • Pfizer Investigational Site
      • Cuise La Motte, France, 60350
        • Pfizer Investigational Site
      • Denain, France, 59220
        • Pfizer Investigational Site
      • Dijon, France, 21000
        • Pfizer Investigational Site
      • Dugny Sur Meuse, France, 55100
        • Pfizer Investigational Site
      • Dunkerque, France, 59140
        • Pfizer Investigational Site
      • Echirolles, France, 38130
        • Pfizer Investigational Site
      • Eckbolsheim, France, 67201
        • Pfizer Investigational Site
      • Eckwersheim, France, 67550
        • Pfizer Investigational Site
      • Epernay, France, 51200
        • Pfizer Investigational Site
      • Epinal, France, 88000
        • Pfizer Investigational Site
      • Epinay Sur Seine, France, 93800
        • Pfizer Investigational Site
      • Etampes, France, 91150
        • Pfizer Investigational Site
      • Etang Sur Arroux, France, 71190
        • Pfizer Investigational Site
      • Evreux, France, 27000
        • Pfizer Investigational Site
      • Falaise, France, 14700
        • Pfizer Investigational Site
      • Fayence, France, 83440
        • Pfizer Investigational Site
      • Fenioux, France, 79160
        • Pfizer Investigational Site
      • Ferney Voltaire, France, 01210
        • Pfizer Investigational Site
      • Floirac, France, 33270
        • Pfizer Investigational Site
      • Fontaine, France, 38600
        • Pfizer Investigational Site
      • Fontaine Les Dijon, France, 21121
        • Pfizer Investigational Site
      • Fontainebleau, France, 77300
        • Pfizer Investigational Site
      • Fontenay Sous Bois, France, 94120
        • Pfizer Investigational Site
      • Fontes, France, 34320
        • Pfizer Investigational Site
      • Fos Sur Mer, France, 13270
        • Pfizer Investigational Site
      • Franconville, France, 95130
        • Pfizer Investigational Site
      • Fumay, France, 08170
        • Pfizer Investigational Site
      • Gaillefontaine, France, 76870
        • Pfizer Investigational Site
      • Gambsheim, France, 67760
        • Pfizer Investigational Site
      • Gap, France, 05000
        • Pfizer Investigational Site
      • Gonesse, France, 95500
        • Pfizer Investigational Site
      • Gonneville La Mallet, France, 76280
        • Pfizer Investigational Site
      • Gradignan, France, 33170
        • Pfizer Investigational Site
      • Grand Couronne, France, 76530
        • Pfizer Investigational Site
      • Greasque, France, 13850
        • Pfizer Investigational Site
      • Grendelbruch, France, 67190
        • Pfizer Investigational Site
      • Grenoble, France, 38100
        • Pfizer Investigational Site
      • Grenoble, France, 38000
        • Pfizer Investigational Site
      • Groslay, France, 95410
        • Pfizer Investigational Site
      • Guise, France, 02120
        • Pfizer Investigational Site
      • Haguenau, France, 67500
        • Pfizer Investigational Site
      • Harnes, France, 62440
        • Pfizer Investigational Site
      • Hasparren, France, 64240
        • Pfizer Investigational Site
      • Hautmont, France, 59330
        • Pfizer Investigational Site
      • Hochfelden, France, 67270
        • Pfizer Investigational Site
      • Hostens, France, 33125
        • Pfizer Investigational Site
      • Ivry Sur Seine, France, 94200
        • Pfizer Investigational Site
      • Jargeau, France, 45150
        • Pfizer Investigational Site
      • Jarville La Malgrange, France, 54140
        • Pfizer Investigational Site
      • Jeumont, France, 59460
        • Pfizer Investigational Site
      • Jeumont Cedex, France, 59571
        • Pfizer Investigational Site
      • L'Isle Sur La Sorgue, France, 84800
        • Pfizer Investigational Site
      • LA Chapelle Sur Erdre, France, 44240
        • Pfizer Investigational Site
      • LA Rochelle, France, 17000
        • Pfizer Investigational Site
      • La Baule, France, 44500
        • Pfizer Investigational Site
      • La Chapelle Des Marais, France, 44410
        • Pfizer Investigational Site
      • La Ciotat, France, 13600
        • Pfizer Investigational Site
      • La Courneuve, France, 93120
        • Pfizer Investigational Site
      • La Creche, France, 79260
        • Pfizer Investigational Site
      • La Fere, France, 02800
        • Pfizer Investigational Site
      • La Francheville, France, 08000
        • Pfizer Investigational Site
      • La Grande Motte, France, 34280
        • Pfizer Investigational Site
      • La Grande Paroisse, France, 77130
        • Pfizer Investigational Site
      • La Tour Du Crieu, France, 09100
        • Pfizer Investigational Site
      • La Trinite Sur Mer, France, 56470
        • Pfizer Investigational Site
      • Labastidette, France, 31600
        • Pfizer Investigational Site
      • Lacrouzette, France, 81210
        • Pfizer Investigational Site
      • Lamagistere, France, 82360
        • Pfizer Investigational Site
      • Lamarque, France, 33460
        • Pfizer Investigational Site
      • Langon, France, 33210
        • Pfizer Investigational Site
      • Lattes, France, 34970
        • Pfizer Investigational Site
      • Laval, France, 53000
        • Pfizer Investigational Site
      • Lavernose Lacasse, France, 31410
        • Pfizer Investigational Site
      • Laxou, France, 54520
        • Pfizer Investigational Site
      • Le Bourget, France, 93350
        • Pfizer Investigational Site
      • Le Cannet, France, 06110
        • Pfizer Investigational Site
      • Le Havre, France, 76600
        • Pfizer Investigational Site
      • Le Havre, France, 76610
        • Pfizer Investigational Site
      • Le Havre, France, 76620
        • Pfizer Investigational Site
      • Lembeye, France, 64350
        • Pfizer Investigational Site
      • Les Issambres, France, 83380
        • Pfizer Investigational Site
      • Les Sables D'Olonne, France, 85100
        • Pfizer Investigational Site
      • Lesquin, France, 59810
        • Pfizer Investigational Site
      • Liancourt, France, 60140
        • Pfizer Investigational Site
      • Ligny En Barrois, France, 55500
        • Pfizer Investigational Site
      • Lille, France, 59000
        • Pfizer Investigational Site
      • Lille, France, 59800
        • Pfizer Investigational Site
      • Limoges, France, 87000
        • Pfizer Investigational Site
      • Lorient, France, 56100
        • Pfizer Investigational Site
      • Lourdes, France, 65100
        • Pfizer Investigational Site
      • Lucheux, France, 80600
        • Pfizer Investigational Site
      • Luxeuil Les Bains, France, 70300
        • Pfizer Investigational Site
      • Lyon, France, 69009
        • Pfizer Investigational Site
      • Lyon, France, 69008
        • Pfizer Investigational Site
      • Mandelieu La Napoule, France, 06210
        • Pfizer Investigational Site
      • Marcq En Baroeul, France, 59700
        • Pfizer Investigational Site
      • Marseille, France, 13006
        • Pfizer Investigational Site
      • Marseille, France, 13013
        • Pfizer Investigational Site
      • Marseille, France, 13009
        • Pfizer Investigational Site
      • Marseille, France, 13004
        • Pfizer Investigational Site
      • Marseille, France, 13008
        • Pfizer Investigational Site
      • Marseille, France, 13012
        • Pfizer Investigational Site
      • Marseille, France, 13015
        • Pfizer Investigational Site
      • Marseille, France, 13002
        • Pfizer Investigational Site
      • Marseille, France, 13010
        • Pfizer Investigational Site
      • Martigues, France, 13500
        • Pfizer Investigational Site
      • Masseret, France, 19510
        • Pfizer Investigational Site
      • Mauguio, France, 34130
        • Pfizer Investigational Site
      • Meaux Beauval, France, 77100
        • Pfizer Investigational Site
      • Meaux-Beauval, France, 77100
        • Pfizer Investigational Site
      • Mennecy, France, 91540
        • Pfizer Investigational Site
      • Mensignac, France, 24350
        • Pfizer Investigational Site
      • Merlimont, France, 62155
        • Pfizer Investigational Site
      • Metz, France, 57000
        • Pfizer Investigational Site
      • Mirabel Et Blacons, France, 26400
        • Pfizer Investigational Site
      • Miramas, France, 13140
        • Pfizer Investigational Site
      • Miramas Cedex, France, 13141
        • Pfizer Investigational Site
      • Miramont De Guyenne, France, 47800
        • Pfizer Investigational Site
      • Mittersheim, France, 57930
        • Pfizer Investigational Site
      • Mommenheim, France, 67670
        • Pfizer Investigational Site
      • Mons En Baroeul, France, 59370
        • Pfizer Investigational Site
      • Montauroux, France, 83440
        • Pfizer Investigational Site
      • Montbeliard, France, 25200
        • Pfizer Investigational Site
      • Monteux, France, 84170
        • Pfizer Investigational Site
      • Montpellier, France, 34000
        • Pfizer Investigational Site
      • Montpellier, France, 34070
        • Pfizer Investigational Site
      • Montreuil, France, 93100
        • Pfizer Investigational Site
      • Montrevel En Bresse, France, 01340
        • Pfizer Investigational Site
      • Moreuil, France, 80110
        • Pfizer Investigational Site
      • Morlaix, France, 29600
        • Pfizer Investigational Site
      • Mourenx, France, 64150
        • Pfizer Investigational Site
      • Muespach, France, 68640
        • Pfizer Investigational Site
      • Mulhouse, France, 68100
        • Pfizer Investigational Site
      • Mulhouse, France, 68200
        • Pfizer Investigational Site
      • Mundolsheim, France, 67450
        • Pfizer Investigational Site
      • Nancy, France, 54000
        • Pfizer Investigational Site
      • Nantes, France, 44000
        • Pfizer Investigational Site
      • Nantes, France, 44100
        • Pfizer Investigational Site
      • Nantes, France, 44200
        • Pfizer Investigational Site
      • Neris Les Bains, France, 03310
        • Pfizer Investigational Site
      • Nevers, France, 58000
        • Pfizer Investigational Site
      • Nice, France, 06000
        • Pfizer Investigational Site
      • Nice, France, 06300
        • Pfizer Investigational Site
      • Nice, France, 06200
        • Pfizer Investigational Site
      • Nice, France, 06 000
        • Pfizer Investigational Site
      • Niort, France, 79000
        • Pfizer Investigational Site
      • Nogent Sur Marne, France, 94130
        • Pfizer Investigational Site
      • Noisiel, France, 77186
        • Pfizer Investigational Site
      • Noyon, France, 60400
        • Pfizer Investigational Site
      • Oberhausbergen, France, 67205
        • Pfizer Investigational Site
      • Obernai, France, 67210
        • Pfizer Investigational Site
      • Objat, France, 19130
        • Pfizer Investigational Site
      • Orange, France, 84100
        • Pfizer Investigational Site
      • Orchamps, France, 39700
        • Pfizer Investigational Site
      • Orry La Ville, France, 60560
        • Pfizer Investigational Site
      • Osses, France, 64780
        • Pfizer Investigational Site
      • Pacy Sur Eure, France, 27210
        • Pfizer Investigational Site
      • Palau Del Vidre, France, 66690
        • Pfizer Investigational Site
      • Paris, France, 75015
        • Pfizer Investigational Site
      • Paris, France, 75019
        • Pfizer Investigational Site
      • Paris, France, 75020
        • Pfizer Investigational Site
      • Paris, France, 75018
        • Pfizer Investigational Site
      • Paris, France, 75013
        • Pfizer Investigational Site
      • Paris, France, 75014
        • Pfizer Investigational Site
      • Paris, France, 75012
        • Pfizer Investigational Site
      • Paris, France, 75017
        • Pfizer Investigational Site
      • Paris, France, 75009
        • Pfizer Investigational Site
      • Paris, France, 75116
        • Pfizer Investigational Site
      • Parthenay, France, 79200
        • Pfizer Investigational Site
      • Perpignan, France, 66100
        • Pfizer Investigational Site
      • Pessac, France, 33600
        • Pfizer Investigational Site
      • Petit Couronne, France, 76650
        • Pfizer Investigational Site
      • Pfulgriesheim, France, 67370
        • Pfizer Investigational Site
      • Phalempin, France, 59133
        • Pfizer Investigational Site
      • Pont A Mousson, France, 54700
        • Pfizer Investigational Site
      • Portet Sur Garonne, France, 31120
        • Pfizer Investigational Site
      • Porto Vecchio, France, 20137
        • Pfizer Investigational Site
      • Poussan, France, 34560
        • Pfizer Investigational Site
      • Pradines, France, 46090
        • Pfizer Investigational Site
      • Precy Sur Oise, France, 60460
        • Pfizer Investigational Site
      • Quimperle, France, 29300
        • Pfizer Investigational Site
      • Rebais, France, 77510
        • Pfizer Investigational Site
      • Reims, France, 51100
        • Pfizer Investigational Site
      • Remiremont, France, 88200
        • Pfizer Investigational Site
      • Rennes, France, 35200
        • Pfizer Investigational Site
      • Rigney, France, 25640
        • Pfizer Investigational Site
      • Rodez Cedex, France, 12001
        • Pfizer Investigational Site
      • Rognac, France, 13340
        • Pfizer Investigational Site
      • Rohrwiller, France, 67410
        • Pfizer Investigational Site
      • Romans Sur Isere, France, 26100
        • Pfizer Investigational Site
      • Roncq, France, 59223
        • Pfizer Investigational Site
      • Roquevaire, France, 13360
        • Pfizer Investigational Site
      • Roubaix, France, 59100
        • Pfizer Investigational Site
      • Roubaix Cedex 1, France, 59071
        • Pfizer Investigational Site
      • Rozay En Brie, France, 77540
        • Pfizer Investigational Site
      • Saint Martin D'Oney, France, 40090
        • Pfizer Investigational Site
      • Saint-etienne, France, 42000
        • Pfizer Investigational Site
      • Salles, France, 33770
        • Pfizer Investigational Site
      • Salon De Provence, France, 13300
        • Pfizer Investigational Site
      • Sanary Sur Mer, France, 83110
        • Pfizer Investigational Site
      • Sarlat La Caneda, France, 24200
        • Pfizer Investigational Site
      • Sartrouville, France, 78500
        • Pfizer Investigational Site
      • Schweighouse Sur Moder, France, 67590
        • Pfizer Investigational Site
      • Selestat, France, 67600
        • Pfizer Investigational Site
      • Semur En Auxois, France, 21140
        • Pfizer Investigational Site
      • Sete, France, 34200
        • Pfizer Investigational Site
      • Sevrier, France, 74320
        • Pfizer Investigational Site
      • Soissons, France, 02200
        • Pfizer Investigational Site
      • Solgne, France, 57420
        • Pfizer Investigational Site
      • St. Agreve, France, 07320
        • Pfizer Investigational Site
      • St. Avold, France, 57500
        • Pfizer Investigational Site
      • St. Brieuc Cedex 1, France, 22015
        • Pfizer Investigational Site
      • St. Denis, France, 93200
        • Pfizer Investigational Site
      • St. Die Des Vosges, France, 88100
        • Pfizer Investigational Site
      • St. Erme Outre Et Ramecourt, France, 02820
        • Pfizer Investigational Site
      • St. Etienne, France, 42100
        • Pfizer Investigational Site
      • St. Fons, France, 69190
        • Pfizer Investigational Site
      • St. Germain Au Mont D'Or, France, 69650
        • Pfizer Investigational Site
      • St. Germain De Marencennes, France, 17700
        • Pfizer Investigational Site
      • St. Girons, France, 09200
        • Pfizer Investigational Site
      • St. Jean De Braye, France, 45800
        • Pfizer Investigational Site
      • St. Jean De Luz, France, 64500
        • Pfizer Investigational Site
      • St. Jean De Maurienne, France, 73300
        • Pfizer Investigational Site
      • St. Joachim, France, 44720
        • Pfizer Investigational Site
      • St. Leu D'Esserent, France, 60340
        • Pfizer Investigational Site
      • St. Leu La Foret, France, 95320
        • Pfizer Investigational Site
      • St. Marcel Les Valence, France, 26320
        • Pfizer Investigational Site
      • St. Martin D'Heres, France, 38400
        • Pfizer Investigational Site
      • St. Martin Des Champs, France, 50300
        • Pfizer Investigational Site
      • St. Martin Du Bois, France, 49500
        • Pfizer Investigational Site
      • St. Morillon, France, 33650
        • Pfizer Investigational Site
      • St. Ouen, France, 93400
        • Pfizer Investigational Site
      • St. Ouen L'Aumone, France, 95310
        • Pfizer Investigational Site
      • St. Rambert D'Albon, France, 26140
        • Pfizer Investigational Site
      • St. Raphael, France, 83700
        • Pfizer Investigational Site
      • St. Remy De Provence, France, 13210
        • Pfizer Investigational Site
      • St. Saulve, France, 59880
        • Pfizer Investigational Site
      • St. Sebastien Sur Loire, France, 44230
        • Pfizer Investigational Site
      • St. Sulpice, France, 81370
        • Pfizer Investigational Site
      • St. Tropez, France, 83990
        • Pfizer Investigational Site
      • St. Yrieix La Perche, France, 87500
        • Pfizer Investigational Site
      • Ste. Maxime, France, 83120
        • Pfizer Investigational Site
      • Ste. Suzanne, France, 53270
        • Pfizer Investigational Site
      • Strasbourg, France, 67000
        • Pfizer Investigational Site
      • Strasbourg, France, 67200
        • Pfizer Investigational Site
      • Suresnes, France, 92150
        • Pfizer Investigational Site
      • Targon, France, 33760
        • Pfizer Investigational Site
      • Tergnier, France, 02700
        • Pfizer Investigational Site
      • Thiant, France, 59224
        • Pfizer Investigational Site
      • Thierville Sur Meuse, France, 55840
        • Pfizer Investigational Site
      • Thiviers, France, 24800
        • Pfizer Investigational Site
      • Thones, France, 74230
        • Pfizer Investigational Site
      • Toul, France, 54200
        • Pfizer Investigational Site
      • Toulon, France, 83000
        • Pfizer Investigational Site
      • Toulon, France, 83200
        • Pfizer Investigational Site
      • Toulouse, France, 31400
        • Pfizer Investigational Site
      • Toulouse, France, 31000
        • Pfizer Investigational Site
      • Toulouse, France, 31200
        • Pfizer Investigational Site
      • Toulouse, France, 31500
        • Pfizer Investigational Site
      • Toulouse, France, 31100
        • Pfizer Investigational Site
      • Tours, France, 37000
        • Pfizer Investigational Site
      • Trie Sur Baise, France, 65220
        • Pfizer Investigational Site
      • Vabres L'Abbaye, France, 12400
        • Pfizer Investigational Site
      • Vacqueyras, France, 84190
        • Pfizer Investigational Site
      • Vagney, France, 88120
        • Pfizer Investigational Site
      • Valenciennes, France, 59300
        • Pfizer Investigational Site
      • Valognes, France, 50700
        • Pfizer Investigational Site
      • Valreas, France, 84600
        • Pfizer Investigational Site
      • Vals Les Bains, France, 07600
        • Pfizer Investigational Site
      • Vandoeuvre Les Nancy, France, 54500
        • Pfizer Investigational Site
      • Vannes, France, 56000
        • Pfizer Investigational Site
      • Varces Allieres Et Risset, France, 38760
        • Pfizer Investigational Site
      • Vatan, France, 36150
        • Pfizer Investigational Site
      • Velines, France, 24230
        • Pfizer Investigational Site
      • Velizy Villacoublay, France, 78140
        • Pfizer Investigational Site
      • Vence, France, 06140
        • Pfizer Investigational Site
      • Venissieux, France, 69200
        • Pfizer Investigational Site
      • Vernet, France, 31810
        • Pfizer Investigational Site
      • Viane, France, 81530
        • Pfizer Investigational Site
      • Villard Bonnot, France, 38190
        • Pfizer Investigational Site
      • Villefranche Sur Mer, France, 06230
        • Pfizer Investigational Site
      • Villefranche Sur Saone, France, 69400
        • Pfizer Investigational Site
      • Villefranche de Rouergue, France, 12200
        • Pfizer Investigational Site
      • Villeneuve Les Maguelone, France, 34750
        • Pfizer Investigational Site
      • Villeparisis, France, 77270
        • Pfizer Investigational Site
      • Villers St. Paul, France, 60870
        • Pfizer Investigational Site
      • Villette D'Anthon, France, 38280
        • Pfizer Investigational Site
      • Viry Chatillon, France, 91170
        • Pfizer Investigational Site
      • Vitrolles, France, 13127
        • Pfizer Investigational Site
      • Vix, France, 85770
        • Pfizer Investigational Site
      • Wambrechies, France, 59118
        • Pfizer Investigational Site
      • Wasselonne, France, 67310
        • Pfizer Investigational Site
      • Wattignies, France, 59139
        • Pfizer Investigational Site
      • Wattrelos, France, 59150
        • Pfizer Investigational Site
      • Witry Les Reims, France, 51420
        • Pfizer Investigational Site
      • Yffiniac, France, 22120
        • Pfizer Investigational Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1.Male or female, 18 years of age or over, 2.Patient with hypertension and at least three other CV risk factors, 3.Hypertension, treated or not, but not at the currently recommended goals (140/90 mmHg for most patients, 130/80 mmHg for patients with diabetes or nephropathy). In case of treated hypertension, patients should be on their current treatment for at least 4 weeks before randomisation,

Exclusion Criteria:

  • 1. Patient with a history of coronary heart disease, 2.Patients with a history of familial hypercholesterolemia, 3.Patient with malignant HTN, 4.Non-essential hypertension, 5.Known hypersensitivity to dihydropyridines, 6.Patients already receiving a dihydropyridine, 7.Known hypersensitivity to HMG-CoA-reductase inhibitors, 8.Patients currently receiving or who has received a HMG-CoA-reductase within the 3 months prior to selection, 9.Patients currently receiving or who has received a fibric acid, resins, ezetimibe, nicotinic acid and all other drug which is known to affect lipid levels, within 6 weeks prior to selection,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
% reduction in Framingham's predicted 10-year risk of a coronary event between V1 and V3 in the Caduet group compared to the usual care group (6) (including diabetic patients)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
1. % patients changing risk category between V1 and V3 2. % reduction in Framingham's predicted 10-year risk of a coronary event (8) excluding diabetic patients 3. Clinical and biological safety during treatment period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2006

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
April 1, 2007

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 27, 2006

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 27, 2006

First Posted (Estimate)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 1, 2006

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 27, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 26, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • A3841038

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings